BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 29502984)

  • 1. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
    Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
    J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
    Katz M; DeRogatis LR; Ackerman R; Hedges P; Lesko L; Garcia M; Sand M;
    J Sex Med; 2013 Jul; 10(7):1807-15. PubMed ID: 23672269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
    Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
    J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
    Simon JA; Thorp J; Millheiser L
    J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
    [No Abstract]   [Full Text] [Related]  

  • 5. Open-label extension study of flibanserin in women with hypoactive sexual desire disorder.
    Jayne C; Simon JA; Taylor LV; Kimura T; Lesko LM;
    J Sex Med; 2012 Dec; 9(12):3180-8. PubMed ID: 23057791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial.
    Simon JA; Kingsberg SA; Shumel B; Hanes V; Garcia M; Sand M
    Menopause; 2014 Jun; 21(6):633-40. PubMed ID: 24281236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
    Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
    J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
    Goldfischer ER; Breaux J; Katz M; Kaufman J; Smith WB; Kimura T; Sand M; Pyke R
    J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.
    Thorp J; Simon J; Dattani D; Taylor L; Kimura T; Garcia M; Lesko L; Pyke R;
    J Sex Med; 2012 Mar; 9(3):793-804. PubMed ID: 22239862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of Flibanserin in Women Treated With Antidepressants: A Randomized, Placebo-Controlled Study.
    Clayton AH; Croft HA; Yuan J; Brown L; Kissling R
    J Sex Med; 2018 Jan; 15(1):43-51. PubMed ID: 29289374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
    Jaspers L; Feys F; Bramer WM; Franco OH; Leusink P; Laan ET
    JAMA Intern Med; 2016 Apr; 176(4):453-62. PubMed ID: 26927498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis.
    Kornstein SG; Simon JA; Apfel SC; Yuan J; Barbour KA; Kissling R
    J Womens Health (Larchmt); 2017 Nov; 26(11):1161-1168. PubMed ID: 28817365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women.
    Pyke RE; Clayton AH
    J Sex Med; 2019 Dec; 16(12):1885-1894. PubMed ID: 31678098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis.
    Gao Z; Yang D; Yu L; Cui Y
    J Sex Med; 2015 Nov; 12(11):2095-104. PubMed ID: 26745616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
    Dhanuka I; Simon JA
    Expert Opin Pharmacother; 2015; 16(16):2523-9. PubMed ID: 26395164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin.
    Simon JA; Clayton AH; Kim NN; Patel S
    Sex Med; 2022 Feb; 10(1):100476. PubMed ID: 34999484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder.
    Simon JA; Clayton AH; Goldstein I; Kingsberg SA; Shapiro M; Patel S; Kim NN
    Sex Med; 2022 Dec; 10(6):100570. PubMed ID: 36400683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin.
    Robinson K; Cutler JB; Carris NW
    Ann Pharmacother; 2016 Feb; 50(2):125-32. PubMed ID: 26692273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Alcohol Administered With Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose Crossover Study.
    Simon JA; Clayton AH; Parish SJ; Apfel SC; Millheiser L
    J Sex Med; 2020 Jan; 17(1):83-93. PubMed ID: 31735618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.
    Clayton AH; Dennerstein L; Pyke R; Sand M
    Womens Health (Lond); 2010 Sep; 6(5):639-53. PubMed ID: 20887163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.